Kim Dong
SEC CIK 1920163 · EDGAR
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| URGN | UroGen Pharma Ltd. | CFO | 37.8K | — | — | 3 | 2024-01-31 | 2024-09-09 |
Most active insiders at URGN, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Schoenberg Mark | Chief Medical Off | — | $4.48M |
| 2 | Smith Jason Drew | GC | — | $211.9K |
| 3 | Degnan Chris | CFO | — | $37.1K |
| 4 | Wildman Daniel George | Dir | — | — |
| 5 | WEN LEANA | Dir | — | — |
| 6 | Holden Stuart | Dir | — | — |
| 7 | Robinson James A. Jr. | Dir | — | — |
| 8 | BUTITTA CYNTHIA M | Dir | — | — |
Kim Dong made no open-market trades at URGN in the last 12 months.
Transactions 3
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-09-12 | 2024-09-09 | URGN | UroGen Pharma Ltd. | Kim Dong | CFO | M - OptEx | — | +2,500 | 37.8K | +7% | — |
| A | 2024-02-12 | 2024-01-31 | URGN | UroGen Pharma Ltd. | Kim Dong | CFO | M - OptEx | — | +3,333 | 35.3K | +10% | — |
| D | 2024-02-02 | 2024-01-31 | URGN | UroGen Pharma Ltd. | Kim Dong | CFO | M - OptEx | — | +3,333 | 26.6K | +14% | — |
Purchase Sale Sale after option exercise All abbreviations